Mimio Health

Welcome to Fasting 2.0

Founded 2020 · $1.8M raised

Employees
1–10
Founded
2020
Total Funding
$1.8M
Last Round
$1.8M SeedMar 2023
Rounds
1

About

Mimio Health is a nutraceutical company pioneering the world's first fasting mimetic supplement, designed from seven years of human clinical research to replicate the cellular health and longevity benefits of a 36-hour fast without requiring dietary restriction. The company's patent-pending formulation delivers a rigorously selected combination of bioactive fasting metabolites that activate the body's natural cellular repair pathways — including autophagy, AMPK, and SIRT — to reduce biological age, support healthy glucose and cholesterol levels, and improve energy and cognitive performance. Mimio has demonstrated a 96% lifespan extension in model organisms and has been featured in Rolling Stone, TechCrunch, Men's Journal, and Vogue. Products are vegan, gluten-free, GMO-free, GMP-certified, and sold direct-to-consumer.

Summary

Mimio Health is a company, founded in 2020. It has raised $1.8M in total across 1 round, most recently a $1.8M Seed round in Mar 2023. Investors include better ventures, 10X Capital and AgFunder.

Tech & App Stack

6 technologies & apps tracked

Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Funding History

Investors